Sun Pharmaceutical Industries Q4 Results: Profit Rises 34%, Beats Estimates
Related Articles
-
Q4 results: Sun Pharma beats profit estimates, declares dividend of ₹5 per share | Company Business News
Hyderabad: Indian drugmaker Sun Pharmaceutical Industries posted fourth-quarter profit above estimates on Wednesday, helped by strong performance in its key U.S. and domestic markets.The company reported a consolidated net profit of ₹2,655 crore ($318.9 million) for the quarter ended March 31, compared to analysts' average estimate of ₹2,368 crore as per LSEG data.ALSO READ: Sun Pharma: 2 key reasons why HSBC expects 16% upside despite regulatory woesIn the year-ago period, the company's...
-
Cardiac Giants do it again, then barely hang on to beat Mets
With a third straight come-from-behind win, the Giants evened their record to .500 for the first time since they were 2-2.
-
AI giant Nvidia blows away earnings estimates
For the better part of the past year, Nvidia has led the stock market. And if that proves true on Thursday, it could be an exciting day. The chipmaker and critical AI component company, on Wednesday, reported first quarter earnings that, as expected, surpassed analyst expectations. Nvidia reported earnings per share of $6.12, compared to an expectation of $5.59 (and stratospherically ahead of last year’s $1.09). Revenues came in at $26.04 billion versus expectations of $24.64 billion. Those...